Haleon PLC Sponsored ADR (NYSE:HLN) Receives Consensus Rating of “Moderate Buy” from Analysts

Shares of Haleon PLC Sponsored ADR (NYSE:HLN) have been assigned a consensus rating of “Moderate Buy” from the ten analysts that are currently covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating, four have issued a buy rating and one has issued a strong buy rating on the company. The average twelve-month price target among analysts that have updated their coverage on the stock in the last year is $12.3250.

A number of equities research analysts have weighed in on HLN shares. Morgan Stanley restated an “overweight” rating on shares of Haleon in a research note on Monday, December 15th. Deutsche Bank Aktiengesellschaft downgraded shares of Haleon from a “hold” rating to a “sell” rating in a research report on Monday, January 12th. Jefferies Financial Group restated a “buy” rating on shares of Haleon in a research note on Tuesday. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Haleon in a research note on Wednesday, October 8th.

Institutional Investors Weigh In On Haleon

A number of institutional investors have recently modified their holdings of the business. New York State Common Retirement Fund purchased a new stake in Haleon in the 2nd quarter valued at about $3,964,000. Archford Capital Strategies LLC purchased a new position in shares of Haleon in the 3rd quarter worth approximately $2,149,000. Acadian Asset Management LLC grew its holdings in shares of Haleon by 3,031.5% in the second quarter. Acadian Asset Management LLC now owns 5,384,661 shares of the company’s stock valued at $55,813,000 after acquiring an additional 5,212,711 shares in the last quarter. JTC Employer Solutions Trustee Ltd increased its position in shares of Haleon by 120.7% during the third quarter. JTC Employer Solutions Trustee Ltd now owns 712,229 shares of the company’s stock valued at $6,392,000 after acquiring an additional 389,467 shares during the last quarter. Finally, Paradiem LLC purchased a new stake in shares of Haleon during the second quarter valued at approximately $1,939,000. Institutional investors own 6.67% of the company’s stock.

Haleon Stock Up 3.0%

NYSE HLN opened at $10.13 on Wednesday. The stock has a market cap of $45.09 billion, a PE ratio of 25.96 and a beta of 0.19. Haleon has a fifty-two week low of $8.71 and a fifty-two week high of $11.42. The business has a 50 day moving average price of $9.82 and a two-hundred day moving average price of $9.60. The company has a quick ratio of 0.63, a current ratio of 0.87 and a debt-to-equity ratio of 0.48.

About Haleon

Haleon plc (NYSE:HLN) is a global consumer healthcare company formed through the separation of a large pharmaceutical group’s consumer health business in 2022. Headquartered in the United Kingdom, Haleon develops, manufactures and markets a broad portfolio of over‑the‑counter medicines, oral health products, vitamins, minerals and supplements, and other consumer health goods designed for daily self‑care and symptom relief.

The company’s product mix spans categories such as oral care (toothpastes and sensitivity treatments), pain relief and analgesics, respiratory remedies, digestive health products, topical treatments and nutritional supplements.